Back to Assenagon Asset Management S.A.

VRTX
Showing 9 of 30 quarters

Position history for Assenagon Asset Management S.A.'s holdings in VERTEX PHARMACEUTICALS INC

Assenagon Asset Management S.A. holds 759,564 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $377.3M as of 2026-Q2. The position was increased (+41.4% shares). VRTX represents 0.5% of Assenagon Asset Management S.A.'s portfolio.

Current Value

$377.3M

Current Shares

759,564

Total Value Change

+$332.2M

Total Shares Change

+663,369

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
759,564
+41.4%
$377.3M0.5%$437.89
50
2026-Q1
Decreased
537,248
-35.5%
$239.9M0.4%$474.27
0
2025-Q4
Increased
832,853
+9.1%
$377.6M0.5%$453.74
48
2025-Q3
Increased
763,703
+214.6%
$299.1M0.4%$395.31
60
2025-Q2
Increased
242,754
+16.6%
$108.1M0.2%$441.30
42
2025-Q1
Decreased
208,140
-75.2%
$100.9M0.2%$492.69
0
2024-Q4
Increased
839,672
+169.4%
$338.1M0.5%$399.35
71
2024-Q3
Increased
311,643
+224.0%
$144.9M0.3%$462.88
58
2024-Q2
Decreased
96,195
-70.2%
$45.1M0.1%$468.72
0

Other major holders of VRTX: Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used